Nuvectis Pharma, Inc. Common Stock
N/A
USD
N/A
N/A
...
Chart
Financials
Description
NVCT Company Description
Nuvectis Pharma Inc is a biopharmaceutical company. The company is engaged in the development of innovative precision medicines for the treatment of serious conditions of unmet medical needs in oncology. It operates with one segment, focused on the development of novel targeted small molecule therapeutics for the treatment of cancer in genetically defined patient populations. Its pipeline products include NXP800, NXP900.
NVCT Stock Smart Score
The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.
The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.
?
Sign Up to view NVCT Smart Score
Score Breakdown
Bull Case vs Bear Case
See concise summaries of analyst reports, presenting both bullish and bearish arguments for a stock.
Example:
Bulls Say:
The Bulls Say summary highlights positive aspects of the stock.
Bears Say:
The Bears Say summary points out potential risks and negative aspects of the stock.
Show More
All
Government
Consumer Interest
SEC Filings
ESG/Other
Recent trades of NVCT by members of U.S. Congress
Recently reported changes by institutional investors
Quarterly net insider trading by NVCT's directors and management
Government lobbying spending instances
U.S. Patents
New patents grants
Government Contracts
Federal grants, loans, and purchases
WallStreetBets
Number of mentions of NVCT in WallStreetBets Daily Discussion
NVCT News
Recent insights relating to NVCT
CNBC Recommendations
Recent picks made for NVCT stock on CNBC
Top ETF Holders
ETFs with the largest estimated holdings in NVCT
Corporate Flights
Flights by private jets registered to NVCT
Our Analysis